Publications by authors named "Jan Mattsson"

Claim this Profile
S
Survival and Quality of Life After Isolated Hepatic Perfusion With Melphalan as a Treatment for Uveal Melanoma Liver Metastases: Final Results From the Phase III Randomized Controlled Trial SCANDIUM.
Roger Olofsson Bagge, Axel Nelson, Amir Shafazand, Charlotta All-Eriksson, Christian Cahlin, Jan Mattsson

Ann Surg· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: 'Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis' [J Hepatol (2024) 80:268-281].
Ahmed Ghallab, Daniela González, Ellen Strängberg, Ute Hofmann, Maiju Myllys, Jan Mattsson

J Hepatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial.
Nadia Ovchinsky, Madeleine Aumar, Alastair Baker, Ulrich Baumann, Philip Bufler, Jan P Mattsson

Lancet Gastroenterol Hepatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis.
Ahmed Ghallab, Daniela González, Ellen Strängberg, Ute Hofmann, Maiju Myllys, Jan Mattsson

J Hepatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans.
Francisco J Caballero-Camino, Pedro M Rodrigues, Fredrik Wångsell, Aloña Agirre-Lizaso, Paula Olaizola, Jan P Mattsson

Hepatology· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variation in response rates to isolated limb perfusion in different soft-tissue tumour subtypes: an international multi-centre study.
Sophie J M Reijers, Emma Davies, Dirk J Grünhagen, Marco Fiore, Charles Honore, Jan Mattsson

Eur J Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis.
Richard J Thompson, Reha Artan, Ulrich Baumann, Pier Luigi Calvo, Piotr Czubkowski, Jan P Mattsson

JHEP Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial).
Roger Olofsson Bagge, Axel Nelson, Amir Shafazand, Charlotta All-Eriksson, Christian Cahlin, Jan Mattsson

J Clin Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers.
Kristy K Broman, Tasha M Hughes, Brooke C Bredbeck, James Sun, Dennis Kirichenko, Jan Mattsson

Ann Surg· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the Introduction of Modern Immunotherapy on the Outcome of Isolated Limb Perfusion for Melanoma In-Transit Metastases.
Carl-Jacob Holmberg, Jan Mattsson, Roger Olofsson Bagge

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial.
Richard J Thompson, Henrik Arnell, Reha Artan, Ulrich Baumann, Pier Luigi Calvo, Jan P Mattsson

Lancet Gastroenterol Hepatol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection.
Zeynep Eroglu, Kristy K Broman, John F Thompson, Amanda Nijhuis, Tina J Hieken, Jan Mattsson

J Immunother Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using a Clinicopathologic and Gene Expression (CP-GEP) Model to Identify Stage I-II Melanoma Patients at Risk of Disease Relapse.
Evalyn E A P Mulder, Iva Johansson, Dirk J Grünhagen, Dennie Tempel, Barbara Rentroia-Pacheco, Jan Mattsson

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of elobixibat on serum and fecal bile acid levels and constipation symptoms in patients with chronic constipation.
Atsushi Nakajima, Sonoko Ishizaki, Kazuki Matsuda, Shinsuke Kurosu, Shinya Taniguchi, Jan P Mattsson

J Gastroenterol Hepatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study.
Ulrich Baumann, Ekkehard Sturm, Florence Lacaille, Emmanuel Gonzalès, Henrik Arnell, Jan P Mattsson

Clin Res Hepatol Gastroenterol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
Kristy Kummerow Broman, Tasha Hughes, Lesly Dossett, James Sun, Dennis Kirichenko, Jan Mattsson

Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis.
Kristy K Broman, Tasha M Hughes, Lesly A Dossett, James Sun, Michael J Carr, Jan Mattsson

J Am Coll Surg· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of tumor-infiltrating CD8 T cells and macrophages correlates to longer overall survival in patients undergoing isolated hepatic perfusion for uveal melanoma liver metastasis.
Junko Johansson, Jan Siarov, Roberta Kiffin, Johan Mölne, Jan Mattsson

Oncoimmunology· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review and Meta-analysis: Partial External Biliary Diversion in Progressive Familial Intrahepatic Cholestasis.
Henkjan J Verkade, Richard J Thompson, Henrik Arnell, Björn Fischler, Per-Göran Gillberg, Jan P Mattsson

J Pediatr Gastroenterol Nutr· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is blood a necessary component of the perfusate during isolated limb perfusion - a randomized controlled trial.
Anna Corderfeldt, Susanne Nielsen, Dimitrios Katsarelias, Anders Hjärpe, Jan Mattsson

Int J Hyperthermia· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF status as a predictive factor for response in isolated limb perfusion.
Valerio Belgrano, Jan Mattsson, Jonas Nilsson, Roger Olofsson Bagge, Dimitrios Katsarelias

Int J Hyperthermia· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimally invasive isolated limb perfusion - technical details and initial outcome of a new treatment method for limb malignancies.
Roger Olofsson Bagge, Per Carlson, Roya Razzazian, Christoffer Hansson, Anders Hjärpe, Jan Mattsson

Int J Hyperthermia· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, long-term safety, and impact on quality of life of elobixibat in more severe constipation: Post hoc analyses of two phase 3 trials in Japan.
Atsushi Nakajima, Shinya Taniguchi, Shinsuke Kurosu, Per-Göran Gillberg, Jan P Mattsson

Neurogastroenterol Motil· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response and Toxicity of Repeated Isolated Limb Perfusion (re-ILP) for Patients With In-Transit Metastases of Malignant Melanoma.
Valerio Belgrano, Jessica Pettersson, Jonas A Nilsson, Jan Mattsson, Dimitrios Katsarelias

Ann Surg Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leakage through the bone-marrow during isolated limb perfusion in the lower extremity.
Dimitrios Katsarelias, John Båth, Per Carlson, Jan Mattsson, Roger Olofsson Bagge

J Surg Case Rep· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis